{"gene":"BCKDHB","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":1991,"finding":"The BCKDHB gene (encoding the E1β subunit of the branched-chain α-keto acid dehydrogenase complex) was chromosomally localized to human chromosome 6p21-22 by somatic cell hybrid analysis and in situ hybridization, establishing its genomic position.","method":"Somatic cell hybrid analysis and in situ hybridization","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct chromosomal mapping by two orthogonal methods (somatic cell hybrids + in situ hybridization), single lab","pmids":["1889817"],"is_preprint":false},{"year":2012,"finding":"Mutations R170H and Q346R in BCKDHB disrupt the E1 component: R170H alters spatial orientation with Y195-β' and S206-α, destabilizing β-β' assembly and the K⁺ ion binding loop of the α subunit; Q346R disrupts conformation between Q346-β and I357-β', reducing β-β' subunit affinity. These residues are therefore critical for E1 activity.","method":"Molecular modeling of missense mutations combined with clinical mutation analysis (Sanger sequencing)","journal":"Gene","confidence":"Low","confidence_rationale":"Tier 4 / Weak — structural inference is solely from in silico modeling, no in vitro biochemical validation","pmids":["22326532"],"is_preprint":false},{"year":2023,"finding":"AAV8-mediated delivery of human BCKDHB cDNA under a ubiquitous EF1α promoter in neonatal Bckdhb-/- mice rescued the lethal MSUD phenotype long-term, demonstrating that hepatic/systemic restoration of BCKDHB expression is sufficient to re-establish functional BCKDH complex activity.","method":"Neonatal AAV gene therapy in Bckdhb knockout mice; biochemical rescue assay (MSUD biomarker normalization)","journal":"Journal of inherited metabolic disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo loss-of-function model with defined phenotypic rescue, single lab, single study","pmids":["36880392"],"is_preprint":false},{"year":2025,"finding":"A dual-function rAAV9 vector co-delivering codon-optimized BCKDHA and BCKDHB (rAAV9.hA-BiP-hB) restored coordinated co-expression of both subunits and BCKDH holoenzyme activity in BCKDHA-deficient HEK293T cells and in Bckdha/Bckdhb knockout mice and a BCKDHA-mutant calf, confirming that both E1α (BCKDHA) and E1β (BCKDHB) must be co-expressed to reconstitute active BCKDH complex.","method":"Dual-gene AAV vector reconstitution in HEK293T cells (enzyme activity assay) and in vivo gene therapy in two knockout mouse models and a newborn calf (biomarker normalization, growth rescue)","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — reconstitution of holoenzyme activity in cells plus in vivo rescue in multiple animal models with orthogonal biochemical readouts","pmids":["40009698"],"is_preprint":false}],"current_model":"BCKDHB encodes the E1β subunit of the mitochondrial branched-chain α-ketoacid dehydrogenase (BCKDH) complex; it must be co-expressed with the E1α subunit (BCKDHA) to form an active E1 heterotetramer, which in turn assembles with E2 (DBT) and E3 (DLD) subunits into the holoenzyme that decarboxylates ketoacid derivatives of leucine, isoleucine, and valine—loss of BCKDHB abolishes this activity and causes maple syrup urine disease, while AAV-mediated restoration of BCKDHB (alone or together with BCKDHA) rescues holoenzyme activity and normalizes branched-chain amino acid metabolism in vivo."},"narrative":{"mechanistic_narrative":"BCKDHB encodes the E1β subunit of the mitochondrial branched-chain α-ketoacid dehydrogenase (BCKDH) complex, the enzyme system responsible for catabolism of the branched-chain amino acids leucine, isoleucine, and valine [PMID:40009698]. Functional reconstitution shows that E1β (BCKDHB) must be co-expressed with E1α (BCKDHA) to form the active E1 component required for holoenzyme activity; co-delivery of both subunits restores BCKDH activity in deficient cells and in vivo, whereas neither subunit alone is sufficient [PMID:40009698]. Restoration of BCKDHB expression alone rescues complex activity in a Bckdhb-null background, establishing that loss of this subunit is the limiting defect in those animals [PMID:36880392]. Loss of BCKDHB activity causes maple syrup urine disease, and AAV-mediated gene delivery normalizes branched-chain amino acid biomarkers and rescues the lethal phenotype in vivo [PMID:36880392, PMID:40009698]. Beyond the requirement for β–β' and β–α subunit contacts in assembling the active E1 component [PMID:22326532], no further mechanistic detail of the catalytic cycle has been characterized in the available corpus.","teleology":[{"year":1991,"claim":"Establishing the genomic position of BCKDHB was the first step toward linking the E1β subunit gene to its locus and to disease mapping.","evidence":"Somatic cell hybrid analysis and in situ hybridization localizing the gene to chromosome 6p21-22","pmids":["1889817"],"confidence":"Medium","gaps":["Does not address protein function or assembly","No connection to enzyme activity demonstrated at this stage"]},{"year":2012,"claim":"Mapping disease-associated missense mutations onto E1 structure addressed which residues are required for subunit assembly, implicating β–β' and β–α interface contacts in E1 integrity.","evidence":"Molecular modeling of R170H and Q346R mutations combined with clinical Sanger sequencing","pmids":["22326532"],"confidence":"Low","gaps":["Structural effects inferred solely from in silico modeling without in vitro biochemical validation","No measurement of residual enzyme activity for the mutant proteins","Assembly defects not confirmed by structural or biophysical methods"]},{"year":2023,"claim":"Whether restoring BCKDHB alone could re-establish functional complex activity was answered by gene-replacement rescue in a knockout model, confirming BCKDHB as the limiting defect in Bckdhb-null animals.","evidence":"Neonatal AAV8 delivery of human BCKDHB cDNA in Bckdhb-/- mice with MSUD biomarker normalization","pmids":["36880392"],"confidence":"Medium","gaps":["Single lab, single study","Does not resolve the stoichiometry or co-assembly requirements with other subunits","Tissue-specific contributions to whole-body rescue not dissected"]},{"year":2025,"claim":"Whether E1α and E1β must be jointly expressed to reconstitute the active E1 component was answered by dual-subunit co-delivery, confirming both BCKDHA and BCKDHB are required to rebuild holoenzyme activity.","evidence":"Dual-gene rAAV9 vector reconstitution in HEK293T cells with enzyme activity assays plus in vivo rescue in two knockout mouse models and a BCKDHA-mutant calf","pmids":["40009698"],"confidence":"High","gaps":["Atomic-resolution structure of the human E1 heterotetramer not determined here","Catalytic mechanism and cofactor handling within the complex not detailed","Regulation of BCKDH activity not addressed"]},{"year":null,"claim":"The catalytic and regulatory mechanism of the BCKDHB-containing E1 component, including its cofactor chemistry and integration with E2/E3 in the holoenzyme, remains uncharacterized in this corpus.","evidence":"","pmids":[],"confidence":"High","gaps":["No experimental structure of the human E1 heterotetramer in the timeline","No direct biochemical dissection of decarboxylation chemistry by BCKDHB-containing E1","Regulatory control of complex activity not addressed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016829","term_label":"lyase activity","supporting_discovery_ids":[3]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[3]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2,3]}],"complexes":["branched-chain α-ketoacid dehydrogenase (BCKDH) complex"],"partners":["BCKDHA"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P21953","full_name":"2-oxoisovalerate dehydrogenase subunit beta, mitochondrial","aliases":["Branched-chain alpha-keto acid dehydrogenase E1 component beta chain","BCKDE1B","BCKDH E1-beta"],"length_aa":392,"mass_kda":43.1,"function":"Together with BCKDHA forms the heterotetrameric E1 subunit of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) complex. The BCKD complex catalyzes the multi-step oxidative decarboxylation of alpha-ketoacids derived from the branched-chain amino-acids valine, leucine and isoleucine producing CO2 and acyl-CoA which is subsequently utilized to produce energy. The E1 subunit catalyzes the first step with the decarboxylation of the alpha-ketoacid forming an enzyme-product intermediate. A reductive acylation mediated by the lipoylamide cofactor of E2 extracts the acyl group from the E1 active site for the next step of the reaction","subcellular_location":"Mitochondrion matrix","url":"https://www.uniprot.org/uniprotkb/P21953/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BCKDHB","classification":"Not Classified","n_dependent_lines":20,"n_total_lines":1208,"dependency_fraction":0.016556291390728478},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BCKDHB","total_profiled":1310},"omim":[{"mim_id":"620699","title":"MAPLE SYRUP URINE DISEASE, TYPE II; MSUD2","url":"https://www.omim.org/entry/620699"},{"mim_id":"620698","title":"MAPLE SYRUP URINE DISEASE, TYPE IB; MSUD1B","url":"https://www.omim.org/entry/620698"},{"mim_id":"614901","title":"BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE KINASE; BCKDK","url":"https://www.omim.org/entry/614901"},{"mim_id":"611065","title":"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1K; PPM1K","url":"https://www.omim.org/entry/611065"},{"mim_id":"608348","title":"BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, ALPHA POLYPEPTIDE; BCKDHA","url":"https://www.omim.org/entry/608348"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Nucleoli","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"liver","ntpm":73.2}],"url":"https://www.proteinatlas.org/search/BCKDHB"},"hgnc":{"alias_symbol":["OVD1B"],"prev_symbol":[]},"alphafold":{"accession":"P21953","domains":[{"cath_id":"3.40.50.970","chopping":"67-251","consensus_level":"high","plddt":98.551,"start":67,"end":251},{"cath_id":"3.40.50.920","chopping":"263-390","consensus_level":"high","plddt":98.7001,"start":263,"end":390}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P21953","model_url":"https://alphafold.ebi.ac.uk/files/AF-P21953-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P21953-F1-predicted_aligned_error_v6.png","plddt_mean":90.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BCKDHB","jax_strain_url":"https://www.jax.org/strain/search?query=BCKDHB"},"sequence":{"accession":"P21953","fasta_url":"https://rest.uniprot.org/uniprotkb/P21953.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P21953/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P21953"}},"corpus_meta":[{"pmid":"30228974","id":"PMC_30228974","title":"Fourteen new mutations of BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease (MSUD) in Malaysian population.","date":"2018","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/30228974","citation_count":18,"is_preprint":false},{"pmid":"26453840","id":"PMC_26453840","title":"Eleven novel mutations of the BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease in the Chinese population: Report on eight cases.","date":"2015","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26453840","citation_count":17,"is_preprint":false},{"pmid":"22326532","id":"PMC_22326532","title":"Two novel mutations in the BCKDHB gene (R170H, Q346R) cause the classic form of maple syrup urine disease (MSUD).","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/22326532","citation_count":17,"is_preprint":false},{"pmid":"28417071","id":"PMC_28417071","title":"Twenty novel mutations in BCKDHA, BCKDHB and DBT genes in a cohort of 52 Saudi Arabian patients with maple syrup urine disease.","date":"2017","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/28417071","citation_count":16,"is_preprint":false},{"pmid":"1889817","id":"PMC_1889817","title":"Regional assignment of two genes of the human branched-chain alpha-keto acid dehydrogenase complex: the E1 beta gene (BCKDHB) to chromosome 6p21-22 and the E2 gene (DBT) to chromosome 1p31.","date":"1991","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1889817","citation_count":15,"is_preprint":false},{"pmid":"28197878","id":"PMC_28197878","title":"Two homozygous mutations in the exon 5 of BCKDHB gene that may cause the classic form of maple syrup urine disease.","date":"2017","source":"Metabolic brain disease","url":"https://pubmed.ncbi.nlm.nih.gov/28197878","citation_count":10,"is_preprint":false},{"pmid":"36880392","id":"PMC_36880392","title":"Successful treatment of severe MSUD in Bckdhb-/- mice with neonatal AAV gene therapy.","date":"2023","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/36880392","citation_count":9,"is_preprint":false},{"pmid":"25381949","id":"PMC_25381949","title":"A new missense mutation in the BCKDHB gene causes the classic form of maple syrup urine disease (MSUD).","date":"2015","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/25381949","citation_count":9,"is_preprint":false},{"pmid":"29366676","id":"PMC_29366676","title":"Two novel mutations in the BCKDHB gene that cause maple syrup urine disease.","date":"2018","source":"Pediatrics and neonatology","url":"https://pubmed.ncbi.nlm.nih.gov/29366676","citation_count":9,"is_preprint":false},{"pmid":"29740478","id":"PMC_29740478","title":"A Novel Whole Gene Deletion of BCKDHB by Alu-Mediated Non-allelic Recombination in a Chinese Patient With Maple Syrup Urine Disease.","date":"2018","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29740478","citation_count":6,"is_preprint":false},{"pmid":"29306928","id":"PMC_29306928","title":"Four novel mutations of the BCKDHA, BCKDHB and DBT genes in Iranian patients with maple syrup urine disease.","date":"2018","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/29306928","citation_count":6,"is_preprint":false},{"pmid":"26239723","id":"PMC_26239723","title":"Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease.","date":"2015","source":"Metabolic brain disease","url":"https://pubmed.ncbi.nlm.nih.gov/26239723","citation_count":6,"is_preprint":false},{"pmid":"40009698","id":"PMC_40009698","title":"BCKDHA-BCKDHB digenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease.","date":"2025","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40009698","citation_count":5,"is_preprint":false},{"pmid":"34187135","id":"PMC_34187135","title":"Neonatal maple syrup urine disease in China: two novel mutations in the BCKDHB gene and literature review.","date":"2021","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/34187135","citation_count":4,"is_preprint":false},{"pmid":"25748408","id":"PMC_25748408","title":"[Maple syrup urine disease caused by two novel BCKDHB gene mutations in a Chinese neonate].","date":"2015","source":"Zhonghua er ke za zhi = Chinese journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/25748408","citation_count":3,"is_preprint":false},{"pmid":"34883003","id":"PMC_34883003","title":"Three novel mutations of the BCKDHA, BCKDHB and DBT genes in Chinese children with maple syrup urine disease.","date":"2021","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/34883003","citation_count":1,"is_preprint":false},{"pmid":"31610500","id":"PMC_31610500","title":"An induced pluripotent stem cell line (SDQLCHi006-A) derived from a patient with maple syrup urine disease type Ib carrying compound heterozygous mutations of p.R168C and p.T322I in BCKDHB gene.","date":"2019","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/31610500","citation_count":1,"is_preprint":false},{"pmid":"33388706","id":"PMC_33388706","title":"An induced pluripotent stem cell line (SDQLCHi033-A) derived from a patient with maple syrup urine disease type Ib carrying a homozygous mutation in BCKDHB gene.","date":"2020","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/33388706","citation_count":1,"is_preprint":false},{"pmid":"30298499","id":"PMC_30298499","title":"[A classic case with maple syrup urine disease caused by compound heterozygous mutations of BCKDHB gene].","date":"2018","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30298499","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10975,"output_tokens":1179,"usd":0.025305,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":7804,"output_tokens":2063,"usd":0.045297,"stage2_stop_reason":"end_turn"},"total_usd":0.070602,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"The BCKDHB gene (encoding the E1β subunit of the branched-chain α-keto acid dehydrogenase complex) was chromosomally localized to human chromosome 6p21-22 by somatic cell hybrid analysis and in situ hybridization, establishing its genomic position.\",\n      \"method\": \"Somatic cell hybrid analysis and in situ hybridization\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct chromosomal mapping by two orthogonal methods (somatic cell hybrids + in situ hybridization), single lab\",\n      \"pmids\": [\"1889817\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Mutations R170H and Q346R in BCKDHB disrupt the E1 component: R170H alters spatial orientation with Y195-β' and S206-α, destabilizing β-β' assembly and the K⁺ ion binding loop of the α subunit; Q346R disrupts conformation between Q346-β and I357-β', reducing β-β' subunit affinity. These residues are therefore critical for E1 activity.\",\n      \"method\": \"Molecular modeling of missense mutations combined with clinical mutation analysis (Sanger sequencing)\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — structural inference is solely from in silico modeling, no in vitro biochemical validation\",\n      \"pmids\": [\"22326532\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"AAV8-mediated delivery of human BCKDHB cDNA under a ubiquitous EF1α promoter in neonatal Bckdhb-/- mice rescued the lethal MSUD phenotype long-term, demonstrating that hepatic/systemic restoration of BCKDHB expression is sufficient to re-establish functional BCKDH complex activity.\",\n      \"method\": \"Neonatal AAV gene therapy in Bckdhb knockout mice; biochemical rescue assay (MSUD biomarker normalization)\",\n      \"journal\": \"Journal of inherited metabolic disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo loss-of-function model with defined phenotypic rescue, single lab, single study\",\n      \"pmids\": [\"36880392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A dual-function rAAV9 vector co-delivering codon-optimized BCKDHA and BCKDHB (rAAV9.hA-BiP-hB) restored coordinated co-expression of both subunits and BCKDH holoenzyme activity in BCKDHA-deficient HEK293T cells and in Bckdha/Bckdhb knockout mice and a BCKDHA-mutant calf, confirming that both E1α (BCKDHA) and E1β (BCKDHB) must be co-expressed to reconstitute active BCKDH complex.\",\n      \"method\": \"Dual-gene AAV vector reconstitution in HEK293T cells (enzyme activity assay) and in vivo gene therapy in two knockout mouse models and a newborn calf (biomarker normalization, growth rescue)\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — reconstitution of holoenzyme activity in cells plus in vivo rescue in multiple animal models with orthogonal biochemical readouts\",\n      \"pmids\": [\"40009698\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BCKDHB encodes the E1β subunit of the mitochondrial branched-chain α-ketoacid dehydrogenase (BCKDH) complex; it must be co-expressed with the E1α subunit (BCKDHA) to form an active E1 heterotetramer, which in turn assembles with E2 (DBT) and E3 (DLD) subunits into the holoenzyme that decarboxylates ketoacid derivatives of leucine, isoleucine, and valine—loss of BCKDHB abolishes this activity and causes maple syrup urine disease, while AAV-mediated restoration of BCKDHB (alone or together with BCKDHA) rescues holoenzyme activity and normalizes branched-chain amino acid metabolism in vivo.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BCKDHB encodes the E1\\u03b2 subunit of the mitochondrial branched-chain \\u03b1-ketoacid dehydrogenase (BCKDH) complex, the enzyme system responsible for catabolism of the branched-chain amino acids leucine, isoleucine, and valine [#3]. Functional reconstitution shows that E1\\u03b2 (BCKDHB) must be co-expressed with E1\\u03b1 (BCKDHA) to form the active E1 component required for holoenzyme activity; co-delivery of both subunits restores BCKDH activity in deficient cells and in vivo, whereas neither subunit alone is sufficient [#3]. Restoration of BCKDHB expression alone rescues complex activity in a Bckdhb-null background, establishing that loss of this subunit is the limiting defect in those animals [#2]. Loss of BCKDHB activity causes maple syrup urine disease, and AAV-mediated gene delivery normalizes branched-chain amino acid biomarkers and rescues the lethal phenotype in vivo [#2, #3]. Beyond the requirement for \\u03b2\\u2013\\u03b2' and \\u03b2\\u2013\\u03b1 subunit contacts in assembling the active E1 component [#1], no further mechanistic detail of the catalytic cycle has been characterized in the available corpus.\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Establishing the genomic position of BCKDHB was the first step toward linking the E1\\u03b2 subunit gene to its locus and to disease mapping.\",\n      \"evidence\": \"Somatic cell hybrid analysis and in situ hybridization localizing the gene to chromosome 6p21-22\",\n      \"pmids\": [\"1889817\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Does not address protein function or assembly\",\n        \"No connection to enzyme activity demonstrated at this stage\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Mapping disease-associated missense mutations onto E1 structure addressed which residues are required for subunit assembly, implicating \\u03b2\\u2013\\u03b2' and \\u03b2\\u2013\\u03b1 interface contacts in E1 integrity.\",\n      \"evidence\": \"Molecular modeling of R170H and Q346R mutations combined with clinical Sanger sequencing\",\n      \"pmids\": [\"22326532\"],\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Structural effects inferred solely from in silico modeling without in vitro biochemical validation\",\n        \"No measurement of residual enzyme activity for the mutant proteins\",\n        \"Assembly defects not confirmed by structural or biophysical methods\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Whether restoring BCKDHB alone could re-establish functional complex activity was answered by gene-replacement rescue in a knockout model, confirming BCKDHB as the limiting defect in Bckdhb-null animals.\",\n      \"evidence\": \"Neonatal AAV8 delivery of human BCKDHB cDNA in Bckdhb-/- mice with MSUD biomarker normalization\",\n      \"pmids\": [\"36880392\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Single lab, single study\",\n        \"Does not resolve the stoichiometry or co-assembly requirements with other subunits\",\n        \"Tissue-specific contributions to whole-body rescue not dissected\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Whether E1\\u03b1 and E1\\u03b2 must be jointly expressed to reconstitute the active E1 component was answered by dual-subunit co-delivery, confirming both BCKDHA and BCKDHB are required to rebuild holoenzyme activity.\",\n      \"evidence\": \"Dual-gene rAAV9 vector reconstitution in HEK293T cells with enzyme activity assays plus in vivo rescue in two knockout mouse models and a BCKDHA-mutant calf\",\n      \"pmids\": [\"40009698\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Atomic-resolution structure of the human E1 heterotetramer not determined here\",\n        \"Catalytic mechanism and cofactor handling within the complex not detailed\",\n        \"Regulation of BCKDH activity not addressed\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The catalytic and regulatory mechanism of the BCKDHB-containing E1 component, including its cofactor chemistry and integration with E2/E3 in the holoenzyme, remains uncharacterized in this corpus.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"No experimental structure of the human E1 heterotetramer in the timeline\",\n        \"No direct biochemical dissection of decarboxylation chemistry by BCKDHB-containing E1\",\n        \"Regulatory control of complex activity not addressed\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016829\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"complexes\": [\n      \"branched-chain \\u03b1-ketoacid dehydrogenase (BCKDH) complex\"\n    ],\n    \"partners\": [\n      \"BCKDHA\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":4,"faith_total":4,"faith_pct":100.0}}